IONOPTIX LLC

IONOPTIX LLC specializes in the design and manufacturing of precision analytical laboratory instruments for biomedical research, with a focused expertise in cardiac tissue analysis and cellular contractility systems. The company develops integrated hardware and software platforms that enable high-resolution measurement of calcium dynamics and mechanical function in excitable tissues, supporting advanced physiological research in cardiology and pharmacology. Their technical capabilities include microfluidic system integration, optical sensing technologies, and real-time data acquisition architectures tailored for in vitro tissue experimentation. A key differentiator is their ability to deliver turnkey instrument systems with embedded preventative maintenance protocols, ensuring long-term operational reliability in sensitive research environments. The contractor has delivered solutions to the Department of Veterans Affairs and the Department of Health and Human Services, primarily supporting biomedical research initiatives involving cardiac tissue modeling and cellular function analysis. These engagements reflect a consistent alignment with federal health research priorities, particularly in developing tools for translational studies in cardiovascular disease and drug response evaluation. IONOPTIX operates within NAICS 334516, which encompasses the manufacturing of analytical laboratory instruments used in life sciences. Their market positioning centers on niche instrumentation for electrophysiology and tissue-based assays, serving research institutions, government labs, and pharmaceutical development programs requiring validated, reproducible measurement systems. The company’s focus is on high-fidelity, non-invasive cellular monitoring technologies that bridge laboratory research and clinical translation. As a small business structured as a 2K entity based in Westwood, Massachusetts, IONOPTIX LLC maintains a lean, engineering-driven operational model. While no formal government certifications are currently listed, their technical delivery and service support infrastructure demonstrate alignment with federal research instrument standards. The company’s geographic presence in a major biomedical innovation corridor enhances its access to academic and federal research partnerships.